Mereo BipPharma Group (MREO) PT Lowered to $3 at Needham Jan 13, 2026 07:11AM
Mereo BipPharma (MREO) Reiterated at Overweight by Cantor Fitzgerald: High-Risk Jan 13, 2026 07:06AM
Mereo BioPharma extends cash runway to mid-2027 after setrusumab trial delays Jan 12, 2026 08:00AM
Leerink on Ultragenyx Pharma (RARE): 'DTX401 Rolling BLA Submitted, Setting Up Launch for Underappreciated Program' Dec 31, 2025 09:23AM
Ultragenyx Pharma (RARE) PT Lowered to $63 at Jefferies Dec 30, 2025 04:55AM


Dec 30, 2025 04:54AM Jefferies Downgrades Mereo BipPharma Group (MREO) to Hold
Dec 29, 2025 03:27PM Ultragenyx Pharma (RARE) PT Lowered to $70 at Leerink Partners
Dec 29, 2025 03:27PM Mereo BipPharma Group (MREO) PT Lowered to $2 at Leerink Partners
Dec 29, 2025 01:24PM Mereo BipPharma Group (MREO) PT Lowered to $1 at BTIG
Dec 29, 2025 01:11PM LifeSci Capital Downgrades Mereo BipPharma Group (MREO) to Market Perform
Dec 29, 2025 12:48PM Ultragenyx Pharma (RARE) PT Lowered to $47 at Baird
Dec 29, 2025 12:21PM Mereo BipPharma Group (MREO) PT Lowered to $1 at Baird
Dec 29, 2025 12:12PM Ultragenyx Pharma (RARE) PT Lowered to $50 (from $103) at Citi
Dec 29, 2025 12:04PM William Blair Reiterates Outperform Rating on Ultragenyx Pharma (RARE)
Dec 29, 2025 12:04PM Leerink Partners Reiterates Outperform Rating on Ultragenyx Pharma (RARE)
Dec 29, 2025 08:25AM Mereo BioPharma (MREO) halted, news pending
Dec 23, 2025 05:41AM Increasing unusual call option volume: XP YANG AMLP LW HNRG CWAN NXDR HTGC RSI
Dec 18, 2025 03:49AM BTIG Reiterates Buy Rating on Mereo BipPharma Group (MREO)
Dec 5, 2025 04:24AM Baird Names Mereo BipPharma Group (MREO) a New Fresh Pick into Clinical Data
Aug 19, 2025 08:32AM ashibio licenses vantictumab from Mereo for rare bone disorder treatment
Aug 12, 2025 08:22AM Mereo BioPharma (MREO) Misses Q2 EPS by 2c
Jul 10, 2025 07:49AM BTIG Reiterates Buy Rating on Mereo BipPharma Group (MREO)
Jul 10, 2025 07:14AM Mereo BipPharma Group (MREO) PT Lowered to $5 at Needham
Jul 10, 2025 06:48AM JPMorgan Reiterates Overweight Rating on Mereo BipPharma Group (MREO)
Jul 9, 2025 04:05PM Ultragenyx and Mereo advance UX143 osteogenesis imperfecta study to final analysis
May 13, 2025 07:51AM Mereo BioPharma Group plc (MREO) Misses Q1 EPS by 3c
Mar 27, 2025 07:38AM Cantor Fitzgerald Reiterates Overweight Rating on Mereo BipPharma Group (MREO)
Mar 27, 2025 02:12AM JPMorgan Starts Mereo BipPharma Group (MREO) at Overweight
Mar 26, 2025 11:56AM BTIG Reiterates Buy Rating on Mereo BipPharma Group (MREO)
Mar 19, 2025 06:43AM Mereo and Ultragenyx remain top picks at Cantor Fitzgerald
Mar 17, 2025 06:43AM Cantor Fitzgerald Reiterates Overweight Rating on Mereo BipPharma Group (MREO)
Feb 26, 2025 05:35AM Increasing unusual call option volume: COMM INFY XLI JACK MREO UMC MRVI BIRK ARVN
Dec 6, 2024 03:00AM Jefferies Starts Mereo BipPharma Group (MREO) at Buy
Nov 25, 2024 04:18PM Mereo BioPharma (MREO) Files for 26.64M Share Offering by Selling Stockholders
Nov 12, 2024 04:46PM Mereo BioPharma Group plc (MREO) Reports In-Line Q3 EPS
Sep 19, 2024 06:42AM Baird Reiterates Outperform Rating on Mereo BipPharma Group (MREO)
Aug 13, 2024 08:55AM Mereo BioPharma Group plc (MREO) Misses Q2 EPS by 1c
Jun 14, 2024 07:51AM Mereo BioPharma (MREO) Prices 12.53M Share Offering at $3.99/sh
Jun 12, 2024 04:08PM Baird Starts Mereo BipPharma Group (MREO) at Outperform
Jun 12, 2024 08:12AM Ultragenyx Pharma (RARE), Mereo BioPharma (MREO) Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) i
Jun 12, 2024 07:30AM Mereo BipPharma Group (MREO) PT Raised to $7 at Needham